These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 24305946)
1. BAG-6, a jack of all trades in health and disease. Binici J; Koch J Cell Mol Life Sci; 2014 May; 71(10):1829-37. PubMed ID: 24305946 [TBL] [Abstract][Full Text] [Related]
2. A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells. Binici J; Hartmann J; Herrmann J; Schreiber C; Beyer S; Güler G; Vogel V; Tumulka F; Abele R; Mäntele W; Koch J J Biol Chem; 2013 Nov; 288(48):34295-303. PubMed ID: 24133212 [TBL] [Abstract][Full Text] [Related]
3. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles. Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836 [TBL] [Abstract][Full Text] [Related]
4. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035 [TBL] [Abstract][Full Text] [Related]
5. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Nedvetzki S; Sowinski S; Eagle RA; Harris J; Vély F; Pende D; Trowsdale J; Vivier E; Gordon S; Davis DM Blood; 2007 May; 109(9):3776-85. PubMed ID: 17218381 [TBL] [Abstract][Full Text] [Related]
6. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. Walwyn-Brown K; Guldevall K; Saeed M; Pende D; Önfelt B; MacDonald AS; Davis DM J Immunol; 2018 Oct; 201(7):2028-2041. PubMed ID: 30120122 [TBL] [Abstract][Full Text] [Related]
9. Natural killer cells: the journey from puzzles in biology to treatment of cancer. Bodduluru LN; Kasala ER; Madhana RM; Sriram CS Cancer Lett; 2015 Feb; 357(2):454-67. PubMed ID: 25511743 [TBL] [Abstract][Full Text] [Related]
10. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. Ferlazzo G; Tsang ML; Moretta L; Melioli G; Steinman RM; Münz C J Exp Med; 2002 Feb; 195(3):343-51. PubMed ID: 11828009 [TBL] [Abstract][Full Text] [Related]
11. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Koch J; Steinle A; Watzl C; Mandelboim O Trends Immunol; 2013 Apr; 34(4):182-91. PubMed ID: 23414611 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression. Kim N; Yi E; Lee E; Park HJ; Kim HS Front Immunol; 2024; 15():1388018. PubMed ID: 38698855 [TBL] [Abstract][Full Text] [Related]
13. Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity. Prajeeth CK; Haeberlein S; Sebald H; Schleicher U; Bogdan C Infect Immun; 2011 Jul; 79(7):2699-708. PubMed ID: 21518784 [TBL] [Abstract][Full Text] [Related]
14. Important role for NKp30 in synapse formation and activation of NK cells. Wang H; Zheng X; Wei H; Tian Z; Sun R Immunol Invest; 2012; 41(4):367-81. PubMed ID: 22221078 [TBL] [Abstract][Full Text] [Related]
15. The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. Hartmann J; Tran TV; Kaudeer J; Oberle K; Herrmann J; Quagliano I; Abel T; Cohnen A; Gatterdam V; Jacobs A; Wollscheid B; Tampé R; Watzl C; Diefenbach A; Koch J J Biol Chem; 2012 Sep; 287(37):31527-39. PubMed ID: 22807449 [TBL] [Abstract][Full Text] [Related]
16. NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Fuller CL; Ruthel G; Warfield KL; Swenson DL; Bosio CM; Aman MJ; Bavari S Cell Microbiol; 2007 Apr; 9(4):962-76. PubMed ID: 17381429 [TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Pogge von Strandmann E; Simhadri VR; von Tresckow B; Sasse S; Reiners KS; Hansen HP; Rothe A; Böll B; Simhadri VL; Borchmann P; McKinnon PJ; Hallek M; Engert A Immunity; 2007 Dec; 27(6):965-74. PubMed ID: 18055229 [TBL] [Abstract][Full Text] [Related]
18. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096 [TBL] [Abstract][Full Text] [Related]
19. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors. Kaifu T; Escalière B; Gastinel LN; Vivier E; Baratin M Cell Mol Life Sci; 2011 Nov; 68(21):3531-9. PubMed ID: 21877119 [TBL] [Abstract][Full Text] [Related]
20. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody. Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]